JP2011507858A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507858A5
JP2011507858A5 JP2010539514A JP2010539514A JP2011507858A5 JP 2011507858 A5 JP2011507858 A5 JP 2011507858A5 JP 2010539514 A JP2010539514 A JP 2010539514A JP 2010539514 A JP2010539514 A JP 2010539514A JP 2011507858 A5 JP2011507858 A5 JP 2011507858A5
Authority
JP
Japan
Prior art keywords
composition
connexin
polynucleotide
drug
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010539514A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507858A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/014022 external-priority patent/WO2009085271A2/en
Publication of JP2011507858A publication Critical patent/JP2011507858A/ja
Publication of JP2011507858A5 publication Critical patent/JP2011507858A5/ja
Pending legal-status Critical Current

Links

JP2010539514A 2007-12-21 2008-12-22 整形外科状態の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた、抗コネキシンペプチドの使用 Pending JP2011507858A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US883407P 2007-12-21 2007-12-21
PCT/US2008/014022 WO2009085271A2 (en) 2007-12-21 2008-12-22 Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions

Publications (2)

Publication Number Publication Date
JP2011507858A JP2011507858A (ja) 2011-03-10
JP2011507858A5 true JP2011507858A5 (https=) 2013-04-25

Family

ID=40824956

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010539514A Pending JP2011507858A (ja) 2007-12-21 2008-12-22 整形外科状態の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた、抗コネキシンペプチドの使用

Country Status (7)

Country Link
US (1) US20110243964A1 (https=)
EP (1) EP2242844A2 (https=)
JP (1) JP2011507858A (https=)
AU (1) AU2008343842A1 (https=)
CA (1) CA2710382A1 (https=)
WO (1) WO2009085271A2 (https=)
ZA (1) ZA201005218B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102073629B1 (ko) 2005-02-03 2020-02-05 코다 테라퓨틱스 (엔지) 리미티드 항-코넥신 화합물 및 그의 용도
UA96457C2 (ru) 2006-08-03 2011-11-10 Нитек Фарма Аг Лечение ревматоидного артрита глюкокортикоидами с отсроченным высвобождением
EP2245158A2 (en) * 2007-12-11 2010-11-03 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
AU2008343840A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions
US8975237B2 (en) 2007-12-21 2015-03-10 Coda Therapeutics, Inc. Treatment of fibrotic conditions
US20110223204A1 (en) * 2008-06-04 2011-09-15 Bradford J Duft Treatment of pain with gap junction modulation compounds
DK2819682T3 (en) 2012-03-01 2017-08-21 Firststring Res Inc TOPICAL GELLS CONTAINING ALPHA-CONNEXIN C-TERMINAL (ACT) PEPTIDES
CN114621346B (zh) 2013-08-21 2025-06-10 德克萨斯州大学系统董事会 用于靶向连接蛋白半通道的组合物和方法
CN107109410B (zh) 2014-08-22 2021-11-02 奥克兰联合服务有限公司 通道调节剂
WO2017147561A1 (en) 2016-02-26 2017-08-31 The Board Of Regents Of The University Of Texas System CONNEXIN (Cx) 43 HEMICHANNEL-BINDING ANTIBODIES AND USES THEREOF
CA3061738A1 (en) 2017-04-28 2018-11-01 Auckland Uniservices Limited Methods of treatment and novel constructs
MX2023004631A (es) 2020-10-22 2023-07-20 Xequel Bio Inc Formulaciones peptidicas y usos oftalmicos de las mismas.
WO2025030173A1 (en) * 2023-08-03 2025-02-06 Next Science IP Holdings Pty Ltd Reducing inflammation in surgical site tissues

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2314321B1 (en) * 1999-01-27 2014-06-04 Coda Therapeutics, Inc. Formulations comprising antisense nucleotides to connexins
JP2003238441A (ja) * 2002-02-08 2003-08-27 英行 ▲高▼野 血管新生抑制剤
CA2536096A1 (en) * 2004-01-30 2005-08-18 Angiotech International Ag Compositions and methods for treating contracture
KR102073629B1 (ko) * 2005-02-03 2020-02-05 코다 테라퓨틱스 (엔지) 리미티드 항-코넥신 화합물 및 그의 용도
US7767710B2 (en) * 2005-05-25 2010-08-03 Calosyn Pharma, Inc. Method for treating osteoarthritis
AU2007319811A1 (en) * 2006-11-15 2008-05-22 Coda Therapeutics, Inc. Improved methods and compositions for wound healing
EP2245158A2 (en) * 2007-12-11 2010-11-03 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments

Similar Documents

Publication Publication Date Title
JP2011507858A5 (https=)
JP2011507860A5 (https=)
JP2011507861A5 (https=)
JP2011506447A5 (https=)
JP2011507855A5 (https=)
AU2003287423B2 (en) Methods and systems for enabling and stabilizing tooth movement
Thiede et al. Pharmacokinetics of sustained-release and transdermal buprenorphine in Göttingen minipigs (Sus scrofa domestica)
JP2009544585A5 (https=)
JP2005512976A5 (https=)
CN109477109A (zh) 靶向人lmna的寡核苷酸类似物
JP2006515351A5 (https=)
HUE029677T2 (hu) Készítmények centrálisan mediált émelygés és hányás kezelésére
JP2011507856A5 (https=)
JP2009519949A5 (https=)
JP2011507859A5 (https=)
EP2139457A2 (en) A drug delivery device for providing local analgesia, local anesthesia or nerve blockade
CN107847565A (zh) 用于肌肉减少症治疗的包括胰高血糖素样肽‑1 受体激动剂的药物组合物
JP2024521091A (ja) 褐色脂肪生成を誘導する方法及び組成物
WO2009150214A3 (en) Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease
IL194500A0 (en) Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application
Bufalari et al. Preemptive carprofen for peri-operative analgesia in dogs undergoing Tibial Plateau Leveling Osteotomy (TPLO): a prospective, randomized, blinded, placebo controlled clinical trial
Chen et al. Systemic penicillin as an experimental model of epilepsy
JPH07508003A (ja) 非経口投与用の安定化ソマトトロピン
CN112156104B (zh) 一种治疗抑郁症的药物
CN114703157B (zh) 多肽及其用于治疗缺血性脑卒中的应用